IACFS 2009-konferentie

 

Sprekers en onderwerpen

 

 

 

 


 

 

 

 

Van 12 tot en met 15 maart 2009 vindt in Reno de IACFS-konferentie 2009 plaats.

 

De IACFS-konferentie is de grootste in zijn soort, met deelnemers uit de hele wereld.

 

Er een speciale konferentie voor patiënten op 12 maart en van 12 tot en met 15 maart zullen er talloze lezingen door researchers en behandelaars gegeven worden.

 

Het voorlopige programma voor beide konferenties is hieronder weergegeven.

 

 


 

Donderdag 12 maart - Professional Workshops

 

9:00am- 12:00pm

Concurrent Workshops

Workshop 1

How to Apply for Grants

Eleanor Hanna, Ph.D.

Associate Director for Special Projects and Centers, Office of Research on Women’s Health, Office of the Director, National Institutes of Health Chair, NIH Working Group on Chronic Fatigue Syndrome, Office of the Director, NIH Advisory Committee, Women’s Health Agenda for the 21st Century, American Psychological Association

Workshop 2

Treating Sleep, Pain & Fatigue Among ME/CFS Patients

Lucinda Bateman, M.D.

Board Member IACFS/ME, Secretary

Director, Fatigue Consultation Clinic, Salt Lake City, UT Adjunct Clinical Faculty, University of Utah School of Medicine, Department of Internal Medicine

Adjunct Instructor, University of Utah,

Family and Preventive Medicine

Charles W. Lapp, M.D.

Assistant Clinical Professor, Duke University Medical Center

Medical Director, Hunter-Hopkins Center

12:00pm - 1:00pm

Lunch Break

1:00pm – 4:00pm

Concurrent Workshops

Workshop 3

Behavioral Assessment and Treatment of ME/CFS

Fred Friedberg, PhD

Board Member IACFS/ME, Treasurer

Assistant Professor, Stony Brook University, Stony Brook, NY

Leonard Jason, PhD

Board Member IACFS/ME, Vice President

Professor, Clinical and Community Psychology, DePaul University, Chicago, IL

Workshop 4

Research 101

Suzanne Vernon, Ph.D.

CFIDS Association of America, Charlotte, NC

 

 

Vrijdag 13 maart - Professional Meeting

 

 

8:00am - 8:15am

Welcome and Introduction

Nancy Klimas, M.D.

Board Member IACFS/ME, President

8:15am – 8:45am

Fatigue Science for Human Health

Yasuyoshi Watanabe, M.D., Ph.D.

Director, RIKEN Center for Molecular Imaging Science

Professor, Osaka City University Graduate School of Medicine, Osaka, Japan

8:45am – 10:00am

Session 1:

Pharmacologic and Non-Pharmacologic Treatment Advances

Chair: Hirohito Kuratsune, M.D., D. Med. Sci.

Designing TLR-therapeutics for treatment of virally-induced and/or immune-complex mediated inflammation and fatigue in animal models of lupus and chronic fatigue syndrome

Petar Lenert, MD, PhD

Response to Treatment in CFS: Evaluation of Combining Cognitive Behavioural Therapy and Graded Exercise Therapy

Greta Moorkens, MD, PhD

The Influence of EMDR and BioFeedback on the Hypervigilance in CFS

Elke Van Hoof, Ph.D.

Alternative Medical Interventions used in the Treatment and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia

Nicole Porter, Ph.D

Interferon and Cytokine Levels in a Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial (AMP-516) of Ampligen® (Poly I : C12U) in CFS

David R. Strayer, M.D

10:00am - 10:15am

Break / Visit Exhibits

10:15am – 11:30pm

Session 1 (Continued):

Pharmacologic and Non-Pharmacologic Treatment Advances

Chair: Fred Friedberg, Ph.D.

The Patients’ own Experiences of Post-Giardiasis Fatigue Syndrome and the Rehabilitation Process Following a Gastrointestinal Infection in 2004

Eva Stormorken RN, MSc.

How is Physical Activity Experienced by CFS Patients? A Focus Group Study

Kirsti Malterud MD, PhD

Calling in Cognitive Behavioral Stress Management for Chronic Fatigue Syndrome

Michael H. Antoni, Ph.D.

Understanding and Overcoming Trauma Induced by CFS/ME, FM, and Other Chronic Conditions

PPatricia A. Fennell, MSW, LCSW-R

Immune and Viral Response to Isoprinosine in Chronic Fatigue Syndrome

Maria Araceli Vera, MD

11:30pm - 1:00pm

Lunch Break/Visit Exhibitors

1:00pm – 2:20pm

Session 5: New Developments in Epidemiology

Chair: Leonard Jason, Ph.D.

Causes of Death in Patients with Chronic Fatigue Syndrome Compared to Deaths in Non-CFS Patients

Rosamund Vallings MB BS

Co-morbid medical and psychiatric conditions in fatigued and well persons: a population study in Georgia, USA

James F. Jones, MD

Revision of exclusion criteria for CFS on pre-existing mental disorders will increase the number of CFS patients by 10%.

Matsui Tokuzo MD, PhD

A case-control study of chronic fatigue syndrome in Swedish Twins

Andreas Jacks, MD

MMental stress symptoms is most strongly associated with fatigue: a population-based comparison of demographic, mental stress, somatic morbidity, and self-rated health variables

Anners Lerdal, RN, PhD

2:20pm – 2:35pm

Break / Visit Exhibits

22:35pm – 4:00pm

Sessions 5 New Developments in Epidemiology (Continued)

Clinical and laboratory characteristics of post-infective fatigue syndrome after acute Q fever: a prospective Australian cohort

Andrew Lloyd MD, PhD

WWork-related risk factors for chronic fatigue

Eliana Mattos Lacerda, MD, PhD

Gynecological history in women with CFS: a population-based study in Wichita, KS

Roumiana S. Boneva, MD, PhD

Classification of Persons with ME/CFS by Types of Fatigue

Aaron Boulton, B.A.

Demonstration of a Correlation between Chronic Fatigue Syndrome (CFS) and the Incidence of NHL in a Nevada Cohort

JJulie Smith Gagen, MPH, PhD

4:00pm – 5:00pm

Session 4: Neuroendocrine Advances

Chair: Gudrun Lange, Ph.D.

Hormonal evaluation in the Chronic Fatigue Syndrome

Andrea Suarez

Adrenergic and Sensory Receptor Expression on Leukocytes Increases After Moderate Exercise in Chronic Fatigue and Fibromyalgia

Alan Light, Ph.D.

Neuropeptide Y (NPY): Correlates with Sympton Severity in Chronic Fatigue Syndrome

Mary Ann Fletcher, Ph.D.

Pre-existing psychological stress predicts acute and Chronic Fatigue Following Symptomatic Parvovirus B19 Infection

Jonathan R. Kerr, M.D., Ph.D.

5:00pm – 5:30pm

Keynote Presentation

Speaker TBD

5:30pm – 6:30pm

Visit Poster Presentations / Exhibits

6:30pm

SSpecial IACFS/ME Fundraising Reception Sponsored by the Whittemore-Peterson Institute for Neuro-Immune Disease

 

 

Zaterdag 14 maart - Professional Meeting

 

 

8:00am – 9:00am

Difficult Clinical Cases Discussed

Nancy Klimas, M.D.

Board Member IACFS/ME, President

Birgitta Evengård, M.D., Ph.D.,

Board Member IACFS/ME, Vice President

Associate Professor, Department Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Lucinda Bateman, M.D.

Board Member, IACFS/ME. Secretary

Fatigue Consultation Clinic, Salt Lake City , UT

9:00am – 10:15am

Session 3: Infectious Disease Research

Chair: Nancy Klimas, M.D.

Herpesvirus and parvovirus B19 DNA in the gastric and intestinal mucosa of patients with chronic fatigue syndrome

Kenny De Meirleir, M.D., Ph.D.

Identification of Differentially Expressed Viruses in American CFS Patients Probed with a custom mammalian virus microarray

Judy A. Mikovits, PhD

High prevalence of IgM antibodies to EBV VCA but not of elevated EBV VCA IgG in patients with CFS

Nadine Unterwalder

Active HHV-6 and HHV-7 Infection and Chronic Fatigue Syndrome

Modra Murovska, MD, PhD

Serological investigation of the role of the Herpes viruses, EBV, CMV and HHV-6 in post-infective fatigue syndrome: a masked case-control study

Barbara Cameron PhD

10:15am – 10:30am

Break/Visit Exhibits

110:30am – 12:00pm

Session 6: The Latest Research in Immunology

Chair: Nancy Klimas, M.D.

TThe Immunological Profile of an Australian Chronic Fatigue Syndrome Female Population

Ekua Weba Brenu HBSc,

Immunological Biomarkers Fail to Discriminate Between CFS and Control Subjects

Christopher R. Snell, Ph.D

Isolating Characteristic Immune Signals under Challenge in Gulf War Illness

Gordon Broderick, Ph.D.

Serum Cytokine and Chemokine Profiles of Individuals with ME/CFS Distinguish Unique Subgroups Amont Patient Populations

Vincent C Lombardi, PhD

Patterns of Cytokine Expression in Chronic Fatigue Syndrome

Nancy G Klimas, M.D.

TThe Importance of Viral vs. Non-Viral Onset Subgrouping in an ME/CFS Community Sample: Differences in Cytokine Production and Expression.

Nicole Porter, Ph.D

12:00pm – 1:15pm

Lunch Break/Visit Exhibitors

Founders Lunch for all Past Presidents:

Networking lunch dedicated to Founders Session; Past presidents (Anthony Komaroff; Dedra Buchwald; Benjamin Natelson; Dharam Ablashi; Nancy Klimas and Ed Taylor

1:15pm – 2:15pm

Session 7: Assessment Issues from Biological to Behavioral

Chair: Fred Friedberg, Ph.D.

An Investigation of CFS Heterogeneity Utilizing Structural Equation Models

Eric Aslakson

Associations between CFS severity measures and changes in MR and brain SPECT images of the brain

Leighton Barnden PhD

A Diagnostic Test for the Identification of Metabolic Dysfunction

J. Mark VanNess, Ph.D.

Chronic fatigue syndrome and mitochondrial dysfunction

Norman E. Booth, Ph D

2:15pm – 2:30pm

Break / Visit Exhibits

22:30pm – 4:30pm

Session 8: New Developments in Pediatric ME/CFS

Chair: Leonard Jason, Ph.D.

Innate immune responses define pediatric CFS

Ritchie C. Shoemaker MD

Examining Criteria to Diagnose ME/CFS in Pediatric Samples

Leonard Jason, Ph.D.

Clinical Characteristics of Belgian Adolescents with Chronic Fatigue

GGreta Moorkens, MD, PhD

Characteristics and recovery of children housebound with CFS/ME

Andrew Haig-Ferguson, BSc (hons), MSc

Do patterns of symptoms suggest distinct subtypes of pediatric chronic fatigue syndrome?

Esther Crawley BA(Hons), BM BCH, FRCPCH, PhD

Screening method of high risk group for childhood chronic fatigue syndrome from healthy students

Sanae Fukuda, Ph.D.

Selective and divided attention in childhood chronic fatigue syndrome

Kei Mizuno, Ph.D.

4:30pm - 5:30pm

Visit Poster Presentations / Exhibits

5:15pm - 6:15pm

IACFS/ME Membership Business Meeting

6:30pm – 7:30pm

IACFS/ME Social/Cocktails Hour

7:30pm - 9:30pm

Banquet Dinner

88:30pm – 9:00pm

Perpich Award

9:00pm – 9:15pm

Junior Investigator Award

9:15pm – 9:30pm

Clinician Award

Special Service Award

Research Award

Research Award

Research Award

 

 

Zondag 15 maart - Professional Meeting

 

 

8:00am - 8:30am

Genomics

Jonathan R. Kerr, M.D., Ph.D.

Consultant in Microbiology, St. George’s Hospital, London, UK Sir Joseph Hotung Senior Lecturer in Inflammation, St. George’s University of London, UK

8:30am – 10:15am

Session 9: Research Developments in Genetics

Chair: Nancy Klimas, M.D.

Gene polymorphism studies support the implication of intestinal dysfunction and activation of the Th17 axis in chronic fatigue syndrome

Marc Fremont, Ph.D.

Microbial Infections in Eight Genomic Subtypes of Chronic Fatigue / Myalgic Encephalomyelitis

Jonathan R Kerr MD, PhD, FRCPath

microRNA expression patterns in chronic fatigue syndrome.

Robert Daniel Petty

A Genomewide Association Study of Chronic Fatigue Syndrome

Mangalathu Rajeevan, PhD

Variation at the HLA and KIR gene loci in Chronic Fatigue Syndrome

Judy A. Mikovits, PhD

Cytokine polymorphisms have a synergistic effect on severity and duration of acute infective illnesses and post-infective fatigue

Andrew Lloyd MD, PhD

10:15am – 10:30am

Break

110:30am – 11:30pm

Session 10: Advances in Brain functioning

Chair: Gudrun Lange, Ph.D.

DDo Physical Complaints Negatively Influence the Information Processing Speed in CFS?

Elke Van Hoof, Ph.D.

Electroencephalographic Data Distinguish Patients with CFS From Healthy and Depressed Controls

Frank H. Duffy, MD

Cognitive Function in Adolescents and Young Adults with Chronic Fatigue Syndrome

Laura Younis BNurs(Prereg), BAppSc(Psych)(Hons), Doctoral Candidate DPsych(Health)

Assessment of Amino Acid Neurotransmitter Function in Chronic Fatigue Syndrome, Major Depressive Disorder and Healthy Volunteers In Vivo using 1H MR Spectroscopy

Dikoma C. Shungu, Ph.D.

11:30pm – 12:45pm

Lunch / Visit Exhibits

12:45pm – 1:45pm

Modeling the Integrative Approach: The Japanese Experience

Co-Chair: Birgitta Evengård, MD, PhD

Co-Chair: Hirohito Kuratsune, M.D.

Development of anti-fatigue food and equipment through animal and human studies

Yasuyoshi Watanabe, MD, PhD

RRelationship between fatigue and daily diet, and assessment of metal task induced fatigue model using heart rate variability analysis

Hirohiko Kuratsune, MD, PhD

Evaluation of labor’s fatigue using chaos analysis

Seiki Tajima, M.D.

Pathophysiology of chronic fatigue syndrome in childhood

Teruhisa Miike, M.D.Ph.D

1:45pm – 2:30pm

Summary of the Conference

Anthony L. Komaroff, M.D.

Simcox-Clifford –Higby Professor of Medicine, Harvard Medical School

2:30pm

Conference ends

 

 

http://www.iacfsme.org/Home/2009ConferenceRegistration/

Professional/ProfessionalAgenda/tabid/339/Default.aspx

 

 


 

Donderdag 12 maart - Patient Meeting

9:30am – 9:45am

Welcome & Introduction

Nancy Klimas, M.D

Board Member IACFS/ME, President

9:45am – 10:45am

New Developments in Possible Causes of ME/CFS

 

Daniel Peterson, M.D.

Anthony L. Komaroff, M.D.

Simcox-Clifford –Higby Professor of Medicine, Harvard Medical School

10:45am – 11:00am

Break

11:00am - 12:00pm

New Research on What Helps People Cope with ME/CFS

 

Fred Friedberg, PhD

Board Member IACFS/ME, Treasurer

Assistant Professor, Stony Brook University, Stony Brook, NY

Leonard Jason, Ph.D.

Board Member IACFS/ME,

Vice President

Professor, Clinical and Community Psychology, DePaul University, Chicago, IL

12:00pm – 1:30pm

Lunch Break

1:30pm – 2:30pm

Latest Research on the Pathophysiology of ME/CFS

 

Board Member IACFS/ME

Hirohito Kuratsune, M.D., D. Med. Sci

Professor, Faculty of Health Science for Welfare, Kansai University of Welfare Sciences

Visiting Professor, Clinical Center for Fatigue Science, Osaka City University Medical School

Kenneth J. Friedman, Ph.D.

Board Member IACFS/ME

Associate Professor of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of NJ

2:30pm – 3:30pm

Assessing ME/CFS Brain Functioning

 

Gudrun Lange, Ph.D.

Clinical Neuropsychologist –Professor, UMDNJ-New Jersey Medical School,

War Related Illness and Injury Study Center, DVA NJ Health Care System

An overview about assessment of cognitive function in CFS/ME. Utility and pitfalls of neuropsychological testing and neuroimaging will be discussed. Questions are encouraged.

3:30pm – 3:45pm

Break

3:45pm – 4:45pm

New Developments in Pharmacologic Treatments

 

Nancy Klimas, M.D.

Board Member IACFS/ME, President

4:45pm - 5:30pm

Panel Question & Answer Session(questions written out)

 

Nancy Klimas, M.D.

Dan Peterson, M.D.

Anthony L. Komaroff, M.D.

Fred Friedberg, Ph.D.

Lenard Jason, Ph.D.

Hirohito Kuratsune, M.D., D. Med. Sci

Kenneth Friedman, Ph.D.

Gudrun Lange, Ph.D

5:30pm

Patient Meeting Concludes

 

 

http://www.iacfsme.org/Home/2009ConferenceRegistration/]

Patient/PatientAgenda/tabid/338/Default.aspx